SEC Form 4 · accession 0001209191-15-087460
Bone Biologics Corp · BBLG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William Jay Treat
Officer — Chief Technology Officer
Period of report
Dec 28, 2015
Accepted (ET)
Dec 31, 2015 · 11:18 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001419554
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $1.59 | Dec 28, 2015 | A | 799,414 | A | — | Dec 27, 2025 | Common Stock | 799,414 | 799,414 | D |
Explanation of responses
- F1532,942 shares subject to the option are immediately exercisable and the remaining shares subject to the option shall vest and become exercisable on September 19, 2016, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2015 Equity Incentive Plan) on such vesting date.